Arcutis Appoints David Topper as Chief Financial Officer
Industry veteran with over 40 years of experience in finance, investment management, and investment bankingWESTLAKE VILLAGE, Calif., April 10, 2024 -- Arcutis Biotherapeutics, Inc. , a...
Stay updated with breaking news from John Smither. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Industry veteran with over 40 years of experience in finance, investment management, and investment bankingWESTLAKE VILLAGE, Calif., April 10, 2024 -- Arcutis Biotherapeutics, Inc. , a...
THE U12 schoolboys’ age-grade will be one of the many highlights of a new season of the 2024 SuperValu West Cork Schoolboys and Schoolgirls
Arcutis Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $-0.65. Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2023 Earnings Call Transcript November 3, 2023 Arcutis Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.73, expectations were $-0.9. Operator: Good day, and welcome to the Arcutis Biotherapeutics Third Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like […]
By Will Feuer Arcutis Biotherapeutics Chief Financial Officer Scott Burrows is expected to leave the company at the end of the month to pursue another...